Swiss pharmaceutical company Novartis reported better-than-expected sales in Q4, with net sales rising 16% to $13.2 billion, exceeding analyst estimates. However, full-year sales fell short of guidance at $50.32 billion, while core operating income for 2024 increased to $19.5 billion. CEO Vas Narasimhan highlighted the company’s strong financial performance and growth outlook for 2025, focusing on advancing their development pipeline with over 30 assets for long-term growth.
Full Article
Pride Flags Slashed at Atlanta L.G.B.T.Q. Landmark, Four Arrested
A group of male youths vandalized Pride flags at a significant rainbow-painted intersection in Midtown Atlanta early Tuesday, prompting police intervention. Four individuals, including three from Dallas, Ga., were arrested and could face additional charges under Georgia's hate crime law, which includes enhanced penalties for offenses motivated by sexual orientation or gender identity. Explain It To Me Like I'm 5: Four young boys were caught by the police for tearing down colorful Pride flags that...
Read more